Pharvaris expects pivotal HAE study data in third quarter 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to Pharvaris expects pivotal HAE study data in third quarter 2026
(NASDAQ: PHVS) Delayed: 32.02 -0.97 (2.94%)
Previous Close $32.99    52 Week High $ 
Open $33.08    52 Week Low $ 
Day High $33.62    P/E N/A 
Day Low $31.96    EPS $ 
Volume 597,655